Trans youth advocates are not asking for hormones to be given to children without oversight. They are defending the established framework of assessed, supervised, specialist-led gender-affirming care supported by major international medical bodies. The debate is about access and delay, not about removing clinical safeguards.
Where does the "no safeguards" claim come from?
It usually starts with a single activist, sometimes a teenager, saying something vivid and quotable on social media. The post gets screenshotted, shared, and held up as proof of what "the trans movement" wants. I understand why that is rhetorically useful. It is also deeply misleading.
One person's colourful rhetoric is not a policy platform. And the people doing serious advocacy work, the clinicians, the legal organisations, the patient groups, the researchers, are not arguing for anything like what those screenshots suggest. They are arguing for something much more specific, and much more grounded in evidence, than "give children hormones with no questions asked."
What the clinical and advocacy consensus actually says
The international framework for gender-affirming care in young people is set out most clearly in the WPATH Standards of Care, currently in their eighth version, and supported by the Endocrine Society, the American Academy of Pediatrics, the American Academy of Child and Adolescent Psychiatry, the World Health Organisation, and the American Medical Association, among others.
That framework involves assessment. It involves families where the young person is a minor. It involves specialist clinicians making individualised decisions. It involves ongoing monitoring once any treatment begins. What it does not involve is handing out hormones to any child who asks, with no professional involvement. That framework has never been what advocates are defending, because it has never been what the guidelines describe.
The actual argument advocates are making is different, and it is worth understanding clearly. They are saying that the assessment process has become so slow, so burdensome, and so politicised in many countries that it no longer functions as clinical care. It functions as a barrier. And barriers have medical consequences.
Why delay is not neutral
This is the part that gets lost when the debate is framed as "safeguards versus no safeguards." The framing assumes that delay is the safe option. It is not.
Puberty does not pause while a waiting list runs. A young person waiting two or three years for an assessment goes through an unwanted puberty in that time. The voice changes, the bone structure changes, the chest changes, and many of those changes are permanent. That is not a neutral outcome; that is harm, real and physical, happening to a real person, while systems that were designed to help them are instead stopping them.
The argument for timely access to care is a medical argument, made by doctors and supported by evidence. It is not impatience. It is biology. Every month of an unwanted puberty is a month of permanent change the young person did not choose and may spend years trying to address later, at much greater cost and with much greater difficulty.
What advocates are actually calling for
When I listen to what serious trans youth advocates, parents of trans children, and the clinicians who work in this field are actually saying, the asks are consistent and specific.
They want assessments that are genuinely clinical, not political. They want waiting times that do not stretch across years of a child's development. They want the clinical evidence to be the basis for decisions, rather than moral panic or media pressure. They want the same standard of care applied to trans young people that is applied without question to other young people with other medical needs. And they want the professionals making decisions to be genuinely expert in this area, rather than generalists who have absorbed the culture war rather than the literature.
None of that is "hormones for children with no oversight." It is the opposite: it is a demand that the oversight be real, competent, and timely, rather than performative and punishing.
The specific interventions being discussed
It helps to be precise about what is actually on the table, because the conversation often blurs distinct things together.
Puberty blockers, medications that pause the progression of puberty, have been used for decades in the treatment of precocious puberty in children who are not trans. Their use in trans young people is an extension of established practice. They are not hormones. They do not cause the permanent changes that cross-sex hormones cause. Their purpose is to give a young person more time to make decisions about the next steps without their body making those decisions for them. The argument for their use is that they are reversible, and that the alternative, an unwanted puberty, is not.
Gender-affirming hormones, testosterone or oestrogen, are typically introduced in adolescence, at an age and stage assessed by clinicians. They are not given to young children. The guidelines are clear about this. Advocates are not arguing otherwise.
In the UK, the private prescription of puberty blockers to trans young people has been banned, and the NHS pathway has effectively collapsed under waiting times that run to years. That ban was not the result of new clinical evidence. It followed political pressure and a review, the Cass Review, that has since been widely discredited by clinicians and researchers internationally. The harm that ban has caused to trans young people is real, documented, and ongoing. Pointing that out is not the same as calling for no clinical oversight. It is the same as pointing out that removing care causes harm.
For parents who saw the post and felt alarmed
If you found this page because something you read frightened you, I want to say something directly to you. Your instinct to protect your child is exactly right. The question is what protection actually looks like.
Protection is not keeping your child away from care. If your child is telling you who they are, and that identity is causing them distress, the evidence is clear that affirming care, at the right pace, with proper clinical support, leads to better outcomes. Delay and denial do not protect young people. They harm them.
The people who want you to fear trans healthcare are not, in most cases, motivated by concern for your child. They are motivated by a desire to reduce the visibility and legitimacy of trans people broadly. Your child's wellbeing is not their priority. It is yours. And understanding what the clinical guidelines actually say, rather than what a screenshot implies, is the best place to start.
For young people reading this
If you are a young person and you are trying to understand what the argument is about, you deserve a straight answer. The adults who are fighting for your access to care are not trying to harm you or remove safety from the process. They are trying to make sure the process works, that it is real, expert, and timely, rather than a system designed to exhaust people into giving up.
What happens next, for you personally, is a conversation that needs to involve the adults in your life and a doctor who can look at where you actually are. That is not me closing the door on you, but the timing matters, and starting that conversation sooner rather than later is worth doing, precisely because puberty does not wait.
The evidence base is not controversial among experts
The clinical evidence supporting gender-affirming care for young people, including puberty blockers and, where appropriate, hormones in adolescence, is endorsed by every major medical and psychiatric body that has reviewed it. The controversy exists in politics and in certain media outlets. It does not exist in the peer-reviewed literature or in the organisations whose job it is to set clinical standards.
Disagreement about trans healthcare among genuine experts is real, but it is mostly about questions of timing, sequencing, and individual assessment, the same kinds of questions that arise in every complex area of medicine. It is not about whether trans young people deserve care. That question has been answered.
The framing of "safeguards versus no safeguards" is not an honest description of the debate. It is a rhetorical move, and it works by making one side sound reckless and the other sound responsible. In reality, the people calling for timely, expert, evidence-based care are the ones taking clinical responsibility seriously. The people calling for delay, barriers, and bans are the ones whose position is not supported by the medical evidence.
If there is a topic that you would like me to cover, just let Sammy know.
Dr Helen Webberley is a Gender Specialist, Medical Educator, writer, and advocate, and the founder of GenderGP. She works full-time in advocacy and public engagement around gender diversity.
Comments